Welcome to our dedicated page for Inception Growth Acqustn SEC filings (Ticker: IGTAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inception Growth Acqustn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inception Growth Acqustn's regulatory disclosures and financial reporting.
Inception Growth Acquisition Limited (IGTA) deposited $13,242.15 into its Trust Account to extend the deadline to complete a business combination from November 13, 2025 to December 13, 2025.
The company also issued a press release, filed as Exhibit 99.1, announcing the extension.
The proxy discloses that stockholders approved proposals to extend the time for Inception Growth Acquisition Ltd (IGTAW) to complete an initial business combination, moving the deadline to October 13, 2025 if fully extended and describing a pathway to a further extension to February 13, 2026 via charter and trust amendments. The company deposited $13,249.65 on June 10, 2025, July 7, 2025 and August 11, 2025 to push the trust termination to September 13, 2025. Each one-month extension requires an aggregate $0.075 per public share contribution to the trust as a loan from the Sponsor, repayable on closing or forgiven if no combination occurs. The filing states the company failed to complete a business combination by December 8, 2024, triggering noncompliance with Nasdaq IM-5101-2, resulting in suspension and delisting from Nasdaq on December 17, 2024, with trading commencing on the OTC Markets the same day. The Sponsor currently owns 42.50% of outstanding shares, and the company flags potential CFIUS review and foreign ownership limitations for U.S. targets.